Chong Kun Dang saw the highest growth of 0.99% in patent filings and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Chong Kun Dang’s patent filings and grants. Buy the databook here.
Chong Kun Dang has been focused on protecting inventions in South Korea(KR) with three publications in Q2 2024
The South Korea(KR) Patent Office dominates the patent filings and grants with nearly 67% filings and 100% grants. The South Korea(KR), and European Patent Office(EPO) patent Office are among the top ten patent offices where Chong Kun Dang is filings its patents. Among the top granted patent authorities, Chong Kun Dang has 100% of its grants in South Korea(KR).
Eli Lilly and Co could be the strongest competitor for Chong Kun Dang
Animal feed related patents lead Chong Kun Dang portfolio followed by pet care, and kidney disease (nephropathy)
Chong Kun Dang has highest number of patents in animal feed followed by pet care, kidney disease (nephropathy).
For comprehensive analysis of Chong Kun Dang's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.